Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid binding protein 5 pseudogene 4 (FABP5P4) is classified as a pseudogene, which means it is a DNA sequence similar to the fatty acid binding protein 5 gene but is generally non-functional due to mutations or deletions that prevent its expression as a functional protein[1]. Pseudogenes do not encode active molecules, are not considered therapeutic targets, and do not participate in known cellular or disease processes. The functional protein in the family, FABP5, is known to regulate fatty acid uptake, intracellular transport, and metabolic pathways, and is implicated in cancer and metabolic disease biology[3][4]. However, FABP5P4 does not contribute to these biological contexts. Key considerations: - FABP5P4 is *not a canonical therapeutic target*, nor does it have protein expression or direct biological function. - If structured data is required for a druggable fatty acid binding protein target, use "Fatty acid binding protein 5 (FABP5)" or other functional isoforms, not this pseudogene. - FABP5P4 may be included in genomic or transcriptomic studies for annotation but does not play an active biochemical or physiological role.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid binding protein 5 pseudogene 4 (FABP5P4).